EP3355902
COMBINATION OF A PD-1 AXIS BINDING ANTAGONIST AND AN ALK INHIBITOR FOR TREATING ALK-NEGATIVE CANCER
:
EP einkaleyfi: Þýðing ekki lögð inn:
27.9.2016:
13.4.2022:
16779272.0
:
26.9.2036
:
COMBINATION OF A PD-1 AXIS BINDING ANTAGONIST AND AN ALK INHIBITOR FOR TREATING ALK-NEGATIVE CANCER
27.9.2016
13.4.2022
:
Merck Patent GmbH:
Frankfurter Strasse 250, 64293 Darmstadt, DE
:
Pfizer Inc.:
235 East 42nd Street, New York, NY 10017, US
:
LIN, Chia-Yang:
Palo Alto, California 94303, US
:
PRIOR, Wei Wei Wu:
Redwood City, CA 94065, US
:
QU, Yan:
Half Moon Bay, California 94019, US
:
WANG, Changyu:
Union City, California 94587, US
:
201562235406 P:
30.9.2015:
US
:
201662385430 P:
9.9.2016:
US
:
201662393609 P:
12.9.2016:
US
:
US2016053939:
27.9.2016
:
A61K 31/439, A61K 31/4545, A61P 35/00